These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 11093785
21. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes. Lee NH, el-Fakahany EE. J Pharmacol Exp Ther; 1991 Feb; 256(2):468-79. PubMed ID: 1993991 [Abstract] [Full Text] [Related]
22. Two allosteric modulators interact at a common site on cardiac muscarinic receptors. Ellis J, Seidenberg M. Mol Pharmacol; 1992 Oct; 42(4):638-41. PubMed ID: 1435741 [Abstract] [Full Text] [Related]
23. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors. Tränkle C, Weyand O, Voigtländer U, Mynett A, Lazareno S, Birdsall NJ, Mohr K. Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174 [Abstract] [Full Text] [Related]
24. Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: radioligand binding studies. Lazareno S, Gharagozloo P, Kuonen D, Popham A, Birdsall NJ. Mol Pharmacol; 1998 Mar; 53(3):573-89. PubMed ID: 9495826 [Abstract] [Full Text] [Related]
25. Probing the selectivity of allosteric modulators of muscarinic receptors at other G-protein-coupled receptors. Pfaffendorf M, Batink HD, Tränkle C, Mohr K, van Zwieten PA. J Auton Pharmacol; 2000 Feb; 20(1):55-62. PubMed ID: 11048962 [Abstract] [Full Text] [Related]
29. Regulation of M2 muscarinic acetylcholine receptor expression and signaling by prolonged exposure to allosteric modulators. May LT, Lin Y, Sexton PM, Christopoulos A. J Pharmacol Exp Ther; 2005 Jan 11; 312(1):382-90. PubMed ID: 15333678 [Abstract] [Full Text] [Related]
33. Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M(2) receptors. Tränkle C, Weyand O, Schröter A, Mohr K. Mol Pharmacol; 1999 Nov 11; 56(5):962-5. PubMed ID: 10531401 [Abstract] [Full Text] [Related]
36. New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo. Schrage R, Holze J, Klöckner J, Balkow A, Klause AS, Schmitz AL, De Amici M, Kostenis E, Tränkle C, Holzgrabe U, Mohr K. Biochem Pharmacol; 2014 Aug 01; 90(3):307-19. PubMed ID: 24863257 [Abstract] [Full Text] [Related]
38. Search for lead structures to develop new allosteric modulators of muscarinic receptors. Tränkle C, Kostenis E, Burgmer U, Mohr K. J Pharmacol Exp Ther; 1996 Nov 01; 279(2):926-33. PubMed ID: 8930201 [Abstract] [Full Text] [Related]
39. Mutational disruption of a conserved disulfide bond in muscarinic acetylcholine receptors attenuates positive homotropic cooperativity between multiple allosteric sites and has subtype-dependent effects on the affinities of muscarinic allosteric ligands. Huang XP, Ellis J. Mol Pharmacol; 2007 Mar 01; 71(3):759-68. PubMed ID: 17132687 [Abstract] [Full Text] [Related]
40. Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors. Proska J, Tucek S. Mol Pharmacol; 1994 Apr 01; 45(4):709-17. PubMed ID: 8183250 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]